Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001828185-25-000039
Filing Date
2025-06-11
Accepted
2025-06-11 17:10:29
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749676222.html 4  
1 FORM 4 wk-form4_1749676222.xml 4 4175
  Complete submission text file 0001828185-25-000039.txt   5834
Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40367 | Film No.: 251040821

Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)